Home / 2015 / March (page 2)

Monthly Archives: March 2015

DPP-4 Inhibitor Saxagliptin May Slow Beta-cell Decline in Type 2

A multinational team of researchers studied data from over 16,000 patients in the SAVOR-TIMI 53 trial…. Saxagliptin (Onglyza) is a commonly prescribed dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes. An international team of researchers examined the effects of saxagliptin on glycemic stability and β-cell function in the …

Read More »

Risk for Dementia Increases in Individuals with Hypertension

But the association with between hypertension, diabetes, and dementia is not clear…. Previous studies have found a correlation between individuals with hypertension and diabetes, and the subsequent development of dementia. The purpose of this cross-sectional study was to analyze the effect of diabetes and hypertension on cognitive scores conducted on …

Read More »

New-Onset Diabetes Benefits from Initial Triple Combination

Initial combination therapy of metformin, pioglitazone, and exenatide might be more effective in reducing HbA1c compared to sequential add-on in new-onset diabetic patients… The purpose of this study is to initiate a therapy regimen that will reduce HbA1c, increase insulin secretion, and increase insulin sensitivity. This therapy will also avoid …

Read More »

Long-term Effects of Type 2 Diabetes Screening

Does screening help reduce the risk of cardiovascular disease for type 2 diabetes patients?… Previous studies have shown that diabetes screening can reduce the risk of cardiovascular disease (CVD) and myocardial infarction. In addition, diabetes screening also helps in detecting and changing unhealthy behaviors. However, self-rated health is often overlooked …

Read More »